口服暴露于微塑料和纳米塑料:为人类健康开发一个模块化和灵活的风险评估框架
Amelie Vogel1, Holger Sieg2, Linda Böhmert2
1German Federal Institute for Risk Assessment (BfR), Berlin, Germany; Technische Universität Berlin, Food Chemistry and Toxicology, Berlin, Germany.
概括
一个新的框架有助于通过口服暴露对微型和纳米塑料 (MNP) 的人类健康风险评估. 它使用现代方法,如新方法方法 (NAMs) 来进行机制性评估.
科学领域:
- 环境科学 环境科学
- 毒理学 毒理学 毒理学
- 风险评估 风险评估
背景情况:
- 微塑料和纳米塑料 (MNP) 越来越严重地影响人类健康.
- 由于物质复杂性,目前MNP的风险评估策略不足.
- 需要标准化方法来评估口服MNP暴露风险.
研究的目的:
- 提出一个高效和灵活的框架来评估MNP对人类健康的风险.
- 为指导风险评估,特别针对口服暴露途径.
- 整合现代方法论,用于对MNP进行机制性评估.
主要方法:
- 开发一个模块化风险评估框架.
- 纳入测试和评估的综合方法 (IATA) 和不良结果途径 (AOP).
- 强调测试和评估的新方法方法 (NAM).
- 它分为三个关键步骤:物理化学表征,肠道穿越和危险评估.
主要成果:
- 介绍了一个结构化的,三步框架,用于MNP风险评估.
- 该框架支持以假设为导向和机械主义的方法.
- 对评估的每一步都概述了科学合理的方法.
结论:
- 拟议的框架为MNP人类健康风险评估提供了一个有效的策略.
- 它提供了一种可靠的方法,用于在口服暴露后评估MNP.
- 纳姆集成使得MNP风险的更全面和机制性理解成为可能.
相关概念视频
Types of Toxins
4.0K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
4.0K
Toxicity Testing in Animals
140
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
140


